Results 171 to 180 of about 1,114,936 (208)
Some of the next articles are maybe not open access.

Management of inflammatory choroidal neovascular membranes

Expert Review of Ophthalmology, 2020
Introduction: Inflammatory choroidal neovascularization (iCNV) is a significant complication of uveitis, leading to vision loss in many cases.
Rachael Niederer   +7 more
openaire   +1 more source

Inflammatory Choroidal Neovascularization: Beyond the Intravitreal Approach

Ocular Immunology and Inflammation, 2017
To describe the importance of a customized combined systemic and local therapy in the management of inflammatory choroidal neovascularization (iCNV).Observational retrospective case series.Four iCNV cases, complicating posterior uveitis or panuveitis affecting young patients, are reported.
Cerquaglia, Alessio   +4 more
openaire   +2 more sources

Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice

open access: yesInvestigative Ophthalmology and Visual Science, 2007
To investigate the role of eicosapentaenoic acid (EPA), the major omega-3 polyunsaturated fatty acid (PUFA), in the development of choroidal neovascularization (CNV), together with underlying molecular mechanisms.Six-week-old C57BL/6 mice were fed with laboratory chow with 5% EPA or the omega-6 PUFA linoleic acid (LA) for 4 weeks.
Hajime Shinoda   +2 more
exaly   +3 more sources

BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION RELATED TO INFLAMMATORY DISEASES

Retina, 2010
The purpose of this study was to report our experience with intravitreal bevacizumab for inflammation-related choroidal neovascularization in two tertiary centers.This study was a retrospective analysis of patients with choroidal neovascularization related to inflammatory diseases, treated with intravitreal bevacizumab injections (1.25 mg/0.05 mL).Ten ...
Michal, Kramer   +10 more
openaire   +2 more sources

Inflammatory choroidal neovascularization: An evidence-based update

Survey of Ophthalmology
Inflammatory choroidal neovascularization (iCNV) significantly contributes to vision impairment and ranks as the third primary cause of CNV. Arising from both infectious and noninfectious uveitis, iCNV's pathogenesis involves Bruch membrane rupture, local inflammation, and choriocapillaris ischemia.
Maria V Cicinelli   +2 more
exaly   +4 more sources

Diagnostic Challenges in Inflammatory Choroidal Neovascular Membranes

Ocular Immunology and Inflammation, 2016
To describe the clinical presentations of inflammatory choroidal neovascular membranes (CNVMs) and factors leading to their delayed diagnosis.Retrospective analysis of chart records and digital images of 60 patients (73 eyes) with inflammatory CNVM (January 1998 to December 2013) to obtain demographic and clinical details, particularly the time of the ...
Reema, Bansal   +6 more
openaire   +2 more sources

Effects of Intravitreal Bevacizumab on Inflammatory Choroidal Neovascular Membrane

European Journal of Ophthalmology, 2012
Purpose. To test the efficacy of intravitreal bevacizumab (IB) in the treatment of inflammatory choroidal neovascularization (CNV). Methods. A prospective interventional study on patients with subfoveal CNV secondary to posterior ...
Iannetti L   +5 more
openaire   +5 more sources

Review for Diagnostics of the Year: Inflammatory Choroidal Neovascularization – Imaging Update

Ocular Immunology and Inflammation, 2022
Inflammatory choroidal neovascularization (iCNV) is a rare complication of uveitis but is a major cause of vision compromise in affected patients. Fluorescein angiography (FA) has been the gold standard for diagnosis. However, it is an invasive modality and when used alone, it might be difficult to distinguish iCNV from inflammatory lesions.
Ghazi Bou Ghanem   +4 more
openaire   +2 more sources

Serum Inflammatory Factors in Patients with Idiopathic Choroidal Neovascularization

Ocular Immunology and Inflammation, 2010
To investigate serum inflammatory factors in patients with idiopathic choroidal vascularization (CNV), including vascular endothelial growth factor (VEGF), tumor necrosis factor alpha (TNFα), Interleukin1-beta (IL1-β), IgG, IgA, IgM, IgE, 50% hemolytic unit of complement (CH50), complement C3, complement C4 and C reactive protein (CRP).21 patients and ...
Fan, Yang   +6 more
openaire   +2 more sources

Efficacy and safety of Aflibercept for the treatment of inflammatory choroidal neovascularization: The ALINEA study

Acta Ophthalmologica, 2022
AbstractPurposeTo evaluate mean change in best‐corrected visual acuity (BCVA) at 52 weeks in patients with inflammatory choroidal neovascularization (CNV) treated with aflibercept.MethodsWe conducted a prospective non‐comparative open‐label trial. Following one mandatory intravitreal injection of aflibercept, patients were treated under a pro re nata ...
Kodjikian, Laurent   +11 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy